Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04484675 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 30, 2025 (before its estimated May 10, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion dates: Feb 1, 2023 to May 10, 2025
    • Start date: Jan 20, 2022 to May 20, 2023
    v5
  2. Primary and study completion dates: Dec 30, 2021 to Feb 1, 2023
    • Start date: Jul 20, 2020 to Jan 20, 2022
    v4
  3. Primary and study completion dates: May 30, 2021 to Dec 30, 2021v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Sep 20, 2020 to May 30, 2021
    • Study sites: 0 to 1
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Zagazig University
115 trials monitored
See 3 trials at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
Hypertension
1,925 trials monitored
See 99 trials at risk
The investigator compared difference between inhaled and intravenous milirinone in patiens with severe pulmonary hypertension undergoing cardiac surgery
Trial Details
NCT Number NCT04484675
Lead Sponsor Zagazig University
Conditions
(from sponsor)		 Pulmonary Hypertension Due to Left Heart Disease
Enrollment 38 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov